MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
Year: 2001
Type: article
Source: PubMed
Authors: B I Lee, S H Park, J W Kim, E A Sausville, H T Kim, O Nakanishi, J B Trepel, S J Kim
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1827980340